Home Biosimilar Antibodies Others Others Anti-CXCR5 / CD185 (SAR113244)
For research use only. Not for use in humans.

Anti-CXCR5 / CD185 (SAR113244)

Synonyms: MU5UBEE

Anti-CXCR5 / CD185 (SAR113244) is a humanized monoclonal antibody that specifically targets CXCR5. It can be used in the treatment of arthritis, autoimmune diseases, inflammatory diseases, graft rejection, and cancer . MW :144.1 KD.

Anti-CXCR5 / CD185 (SAR113244)

Quality Control

Batch: A264701 Purity: 99% Protein concentration: 3.95mg/ml Endotoxin Level: ＜1EU/mg
99

Mechanism of Action

Description
Anti-CXCR5 / CD185 (SAR113244) is a humanized monoclonal antibody that specifically targets CXCR5. It can be used in the treatment of arthritis, autoimmune diseases, inflammatory diseases, graft rejection, and cancer . MW :144.1 KD.
References

Product Details

Molecular Weight 144.1
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100 mM Pro-Ac, 20mM Arg, pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Clinical Trial Information

NCT Number Recruitment interventions Conditions Sponsor/Collaborators Start Date Phases
NCT02331810 WITHDRAWN Drug: SAR113244|Drug: placebo Systemic Lupus Erythematosus Sanofi 2016-04 PHASE1
NCT02321709 COMPLETED Drug: SAR113244|Drug: placebo Systemic Lupus Erythematosus Sanofi 2014-11 PHASE1

(data from https://clinicaltrials.gov, updated on 2016-06-03)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.